Alan B Lancz & Associates, Inc. / JNJ
Alan B Lancz & Associates, Inc.’s Johnson & Johnson Position
Does Alan B Lancz & Associates, Inc. own Johnson & Johnson (JNJ)? Yes — 5.5K shares worth $1M (+1.31% of its 13F portfolio) as of Q1 2026, down from 6.3K shares the prior filed quarter.
Position Value
$1M
Q1 2026
Shares
5.5K
% of Portfolio
+1.31%
Quarters Held
17
currently held
Position History JNJ
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 5.5K | $1M | +1.31% |
| Q4 2025 | 6.3K | $1M | +1.15% |
| Q3 2025 | 6.3K | $1M | +1.06% |
| Q2 2025 | 6.3K | $963,395 | +0.96% |
| Q1 2025 | 6.4K | $1M | +1.12% |
| Q4 2024 | 6.4K | $919,350 | +0.93% |
| Q3 2024 | 6.5K | $1M | +0.96% |
| Q2 2024 | 6.5K | $943,756 | +0.93% |
| Q4 2023 | 6.4K | $998,278 | +1.05% |
| Q3 2023 | 6.4K | $991,972 | +1.13% |
| Q2 2023 | 7.1K | $1M | +1.25% |
| Q1 2023 | 7.1K | $1M | +1.14% |
| Q4 2022 | 7.1K | $1M | +1.25% |
| Q3 2022 | 7.1K | $1M | +1.38% |
| Q2 2022 | 7.2K | $1M | +1.25% |
| Q1 2022 | 8.0K | $1M | +1.26% |
| Q4 2021 | 16.0K | $3M | +0.64% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Alan B Lancz & Associates, Inc.’s full portfolio or all institutional holders of JNJ.